Literature DB >> 6415933

Stimulation of the faecal excretion of 2,4,5,2',4',5'-hexachlorobiphenyl in rats by squalane.

E Richter, S G Schäfer, B Fichtl.   

Abstract

Faecal excretion of 2,4,5,2',4',5'-hexachlorobiphenyl (6-CB) was followed for 19 weeks in rats fed a control diet, or a squalane-supplemented diet, for up to 17 weeks. In 3 d after a single oral dose of 8 mg/kg of 6-CB, 20% dose was excreted in faeces as unchanged 6-CB, which probably represents that not-absorbed. From day 4 to 133 only an additional 2-4% dose was excreted in faeces by control animals. Addition of 8% squalane to the diet 2, 6 and 15 weeks after dosing resulted in a five-fold increase of daily 6-CB excretion in faeces independent of the time of beginning the treatment. Total excretion of 6-CB in faeces from day 4 to 133 was 3.6, 6-7 and 9.3% dose after 4, 13 and 17 weeks of squalane treatment, respectively. No adverse effects of long-term squalane treatment on body-weight gain, feed efficiency and organ weights were observed. Plasma cholesterol and triglycerides were significantly lowered. Independent of the duration of treatment, the livers of rats fed the squalane-supplemented diet contained 40-50 micrograms/g squalane. Within the limits of detection no squalane could be found in lungs, kidneys, abdominal fat, spleen and blood. It is concluded that 6-CB elimination can be enhanced by oral treatment with squalane even a long time after uptake of the poison. As there was no alteration in the tissue distribution of 6-CB, the 6-CB excreted after squalane treatment probably originates from all tissues.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6415933     DOI: 10.3109/00498258309052272

Source DB:  PubMed          Journal:  Xenobiotica        ISSN: 0049-8254            Impact factor:   1.908


  3 in total

Review 1.  Factors affecting the storage and excretion of toxic lipophilic xenobiotics.

Authors:  R J Jandacek; P Tso
Journal:  Lipids       Date:  2001-12       Impact factor: 1.880

2.  Current state of yusho and prospects for therapeutic strategies.

Authors:  Chikage Mitoma; Hiroshi Uchi; Kiyomi Tsukimori; Takashi Todaka; Jumboku Kajiwara; Takayuki Shimose; Manabu Akahane; Tomoaki Imamura; Masutaka Furue
Journal:  Environ Sci Pollut Res Int       Date:  2017-12-01       Impact factor: 4.223

Review 3.  Aryl Hydrocarbon Receptor and Dioxin-Related Health Hazards-Lessons from Yusho.

Authors:  Masutaka Furue; Yuji Ishii; Kiyomi Tsukimori; Gaku Tsuji
Journal:  Int J Mol Sci       Date:  2021-01-12       Impact factor: 5.923

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.